Atrix granted stay in patent infringement case over LHRH therapy


The U.S. District Court for the Northern District of Illinois has issued an order granting Atrix Laboratories' motion to stay the patent infringement suit filed by TAP Pharmaceutical Products, Inc., Takeda Chemical Industries, Ltd., and Wako Pure Chemical Industries, Ltd., according to an Atrix press release.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.